rucaparib and ariel3 – positive results from the phase 3 trial in ovarian cancer patients
Published 6 years ago • 967 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
9:31
ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma
-
3:07
rucaparib maintenance and monotherapy for ovarian cancer: trial updates
-
9:24
results from the engot-ov16/nova trial: efficacy and safety of niraparib in ovarian cancer
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
1:44
the delivery of niraparib and rucaparib as ovarian cancer treatment options
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
1:42
phase iii results for rucaparib in ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
1:53
parp inhibitors: game-changers for ovarian cancer patients?
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
9:22
rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...